Patent · US Active

Agents that inhibit the binding of CFH to CD11 b/CD18 and uses thereof

US11072661B2 · kind B2 · utility

0Cited by

2References

6Claims

0Family size

Assignees

Sorbonne Universite · FR
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE · FR
INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) · FR

Inventors

Florian Sennlaub · Paris, FR
Bertrand Callippe · Paris, FR
Xavier Guillonneau · Boulogne-Billancourt, FR
Jose-Alain Sahel · Paris, FR

Key dates

Filing date	Dec 23, 2016
Grant date	Jul 27, 2021
Priority date	—
Expiry date	Dec 23, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/76
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are agents inhibiting the interaction between CFH and CD11b/18, as well as the use of such agents, in particular for treating inflammatory disorders, such as age-related macular degeneration.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.